Cargando…

Efficacy and safety of basal-bolus insulin at 1:1.5 ratio compared to 1:1 ratio using a weight-based initiation and titration (WIT2) algorithm in hospitalized patients with type 2 Diabetes: a multicenter, randomized, clinical study

BACKGROUND: Most studies initiated basal-bolus insulin in a ratio of 1:1 and titrated based on glucose. This study aimed to investigate the effectiveness and safety of a weight-based and ratio of 1:1.5 basal-bolus insulin using an algorithm for both initiation and titration in hospitalized patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xiaodan, Yan, Dewen, Du, Tao, Zhao, Yunjuan, Zhang, Jiangong, Zhang, Tong, Lin, Mingrun, Li, Yanli, Li, Wangen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680246/ https://www.ncbi.nlm.nih.gov/pubmed/38008775 http://dx.doi.org/10.1186/s13098-023-01193-9

Ejemplares similares

Comparison of weight-based insulin titration (WIT) and glucose-based insulin titration using basal-bolus algorithm in hospitalized patients with type 2 diabetes: a multicenter, randomized, clinical study
por: Zhang, Xiaodan, et al.
Publicado: (2020)

Lack of coordination between partners: investigation of Physician-Preferred and Patient-Preferred (4P) basal insulin titration algorithms in the real world
por: Zhang, Tong, et al.
Publicado: (2018)

The basal to total insulin ratio in outpatients with diabetes on basal-bolus regimen
por: Castellano, Elena, et al.
Publicado: (2018)

Correction to: The basal to total insulin ratio in outpatients with diabetes on basal-bolus regimen
por: Castellano, Elena, et al.
Publicado: (2018)

Rationale for, Initiation and Titration of the Basal Insulin/GLP-1RA Fixed-Ratio Combination Products, IDegLira and IGlarLixi, for the Management of Type 2 Diabetes
por: Valentine, Virginia, et al.
Publicado: (2017)

Initiating Titratable Fixed-Ratio Combinations of Basal Insulin Analogs and Glucagon-Like Peptide-1 Receptor Agonists: What You Need to Know
por: Skolnik, Neil, et al.
Publicado: (2018)

Titratable fixed‐ratio combination of basal insulin plus a glucagon‐like peptide‐1 receptor agonist: A novel, simplified alternative to premix insulin for type 2 diabetes
por: Gomez‐Peralta, Fernando, et al.
Publicado: (2021)

Feasibility of Simplification From a Basal-Bolus Insulin Regimen to a Fixed-Ratio Formulation of Basal Insulin Plus a GLP-1RA or to Basal Insulin Plus an SGLT2 Inhibitor: BEYOND, a Randomized, Pragmatic Trial
por: Giugliano, Dario, et al.
Publicado: (2021)

Challenging the 50‐50 rule for the basal‐bolus insulin ratio in patients with type 2 diabetes who maintain stable glycaemic control
por: Harper, Roy, et al.
Publicado: (2022)

Basal insulin titration by the app
por: Vangoitsenhoven, Roman, et al.
Publicado: (2023)

Long-term inhibition of dipeptidyl-peptidase 4 reduces islet infiltration and downregulates IL-1β and IL-12 in NOD mice
por: He, Xinran, et al.
Publicado: (2020)

Basal-bolus or premixed? Shedding light on optimal insulin regime for type 1 diabetes
por: Louise Walton, Emma
Publicado: (2018)

Prognostic significance of the angiopoietin-2/angiopoietin-1 and angiopoietin-1/Tie-2 ratios for early sepsis in an emergency department
por: Fang, Yingying, et al.
Publicado: (2015)

Evaluation of the Thyroid Characteristics and Correlated Factors in Hospitalized Patients with Newly Diagnosed Type 2 Diabetes
por: Li, Yanli, et al.
Publicado: (2022)

Reducing variability in dual bolus cardiac MRI by using empirical contrast ratios
por: Chatterjee, Neil, et al.
Publicado: (2016)

Transitioning from basal–bolus or premix insulin therapy to a combination of basal insulin and glucagon‐like peptide‐1 receptor agonist in people with type 2 diabetes
por: Mehta, Roopa, et al.
Publicado: (2022)

Identification of the prognostic value of Th1/Th2 ratio and a novel prognostic signature in basal-like breast cancer
por: Xiao, Yu, et al.
Publicado: (2023)

Assessment of Patient-Led or Physician-Driven Continuous Glucose Monitoring in Patients With Poorly Controlled Type 1 Diabetes Using Basal-Bolus Insulin Regimens: A 1-year multicenter study
por: Riveline, Jean-Pierre, et al.
Publicado: (2012)

Measurement of an upper limit of the ratio $K_{S} \rightarrow 2\gamma / K_{1} \rightarrow 2\gamma$ and of the $K_{1} \rightarrow 2\gamma$ branching ratio
por: Wolff, B, et al.
Publicado: (1971)

Appropriate Titration of Basal Insulin in Type 2 Diabetes and the Potential Role of the Pharmacist
por: Patel, Dhiren, et al.
Publicado: (2019)

Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and prognostic nutritional index for predicting clinical outcomes in T1–2 rectal cancer
por: Xia, Li-jian, et al.
Publicado: (2020)

Switching from basal or basal-bolus insulin to biphasic insulin aspart 30: Results from the Indian cohort of the A(1) chieve study
por: Bhattacharyya, Arpandev, et al.
Publicado: (2014)

Short Report: Treatment Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal–bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN® Basal–Bolus Type 1): 2-year results of a randomized clinical trial
por: Bode, B W, et al.
Publicado: (2013)

Efficacy and Safety of iGlarLixi, Fixed-Ratio Combination of Insulin Glargine and Lixisenatide, Compared with Basal-Bolus Regimen in Patients with Type 2 Diabetes: Propensity Score Matched Analysis
por: Tabák, Ádám G., et al.
Publicado: (2019)

Safety and Effectiveness of Insulin Aspart in Basal-Bolus Regimens Regardless of Age: A(1)chieve Study Results
por: Latif, Zafar A., et al.
Publicado: (2013)

Safety and efficacy of insulin degludec/insulin aspart with bolus mealtime insulin aspart compared with standard basal–bolus treatment in people with Type 1 diabetes: 1–year results from a randomized clinical trial (BOOST (®) T1)
por: Hirsch, I. B., et al.
Publicado: (2016)

NLRP3 Inflammasome: Checkpoint Connecting Innate and Adaptive Immunity in Autoimmune Diseases
por: Zhang, Yiwen, et al.
Publicado: (2021)

The role of sulfonylurea plus basal insulin on glycemic variability compared to basal bolus regime in T2D patients
por: Freire, Paula Vieira, et al.
Publicado: (2015)

Laminar analysis of the cortical T1/T2-weighted ratio at 7T
por: Petracca, Maria, et al.
Publicado: (2020)

Fixed-Ratio combinations (Basal Insulin Plus GLP-1RA) in Type 2 diabetes. An analytical review of pivotal clinical trials
por: Vargas-Uricoechea, Hernando, et al.
Publicado: (2023)

The effect of basal–bolus therapy varies with baseline 1,5‐anhydroglucitol level in people with Type 2 diabetes: a post hoc analysis
por: Heller, S., et al.
Publicado: (2018)

A Ratio Model of L(1)/L(2) Norm for Sound Source Identification
por: Huang, Linsen, et al.
Publicado: (2020)

Slow Titration and Delayed Intensification of Basal Insulin Among Patients with Type 2 Diabetes
por: Mocarski, Michelle, et al.
Publicado: (2018)

Comparison of Basal-Bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes
por: Bellido, Virginia, et al.
Publicado: (2015)

A basal-bolus insulin regimen integrated microneedle patch for intraday postprandial glucose control
por: Chen, Bo Zhi, et al.
Publicado: (2020)

Optimization of skin dose using in‐vivo MOSFET dose measurements in bolus/non‐bolus fraction ratio: A VMAT and a 3DCRT study
por: Dias, Anabela G., et al.
Publicado: (2019)

Ratios of T-helper 2 Cells to T-helper 1 Cells and Cytokine Levels in Patients with Hepatitis B
por: Li, Ming-Hui, et al.
Publicado: (2017)

The importance of the initial period of basal insulin titration in people with diabetes
por: Khunti, Kamlesh, et al.
Publicado: (2020)

Impact of the Fasting Plasma Glucose Titration Target on the Success of Basal Insulin Titration in Insulin-Naïve Patients with Type 2 Diabetes: A Systematic Analysis
por: Wolters, Jannik, et al.
Publicado: (2022)

Insights into optimal basal insulin titration in type 2 diabetes: Results of a quantitative survey
por: Berard, Lori, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_47tao4bu6qbrmsc75sgoatelsg